With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

Investors who adopt systems thinking when approaching the space economy can enhance their ability to understand and influence ...

Master director David Cronenberg continues to explore squirm-making subjects, always thoughtfully, here with a well-cast ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

While the list included new and old faces, there was not a single Indian to feature in the list. Last year, several Indian ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and ...

Colossal Biosciences "resurrects" dire wolves with genetic editing, sparking ethical and ecological concerns in conservation ...

Despite 2024 top-line numbers some analysts found disappointing, L’Oréal doubled down on profits, achieving record gross and ...

The Summer Fridays Jet Lag Mask has been a viral cult hit since its launch. Now, meet the Jet Lag Eye Patches, a set of ...